Results 151 to 160 of about 344 (178)
Some of the next articles are maybe not open access.
1987
Plants of the genus Cannabis are known to produce stronger and more immediate effects when smoked, the usual way of administration in Western countries, than when orally taken in similar amounts. In particular, the psychoactive effects are stronger than could be expected from the initial tetrahydrocannabinol (THC) content (Galanter et al.
openaire +2 more sources
Plants of the genus Cannabis are known to produce stronger and more immediate effects when smoked, the usual way of administration in Western countries, than when orally taken in similar amounts. In particular, the psychoactive effects are stronger than could be expected from the initial tetrahydrocannabinol (THC) content (Galanter et al.
openaire +2 more sources
International Review of Psychiatry, 2009
Recent advances in knowledge about cannabinoid receptor function have renewed interest in the association between cannabis and psychosis. Case series, autobiographical accounts, and surveys of cannabis users in the general population suggest an association between cannabis and psychosis.
R Andrew, Sewell +2 more
openaire +2 more sources
Recent advances in knowledge about cannabinoid receptor function have renewed interest in the association between cannabis and psychosis. Case series, autobiographical accounts, and surveys of cannabis users in the general population suggest an association between cannabis and psychosis.
R Andrew, Sewell +2 more
openaire +2 more sources
The American Journal of the Medical Sciences, 2015
Synthetic cannabinoids (SCBs), also known under the brand names of "Spice," "K2," "herbal incense," "Cloud 9," "Mojo" and many others, are becoming a large public health concern due not only to their increasing use but also to their unpredictable toxicity and abuse potential.
Brooke, Mills +2 more
openaire +2 more sources
Synthetic cannabinoids (SCBs), also known under the brand names of "Spice," "K2," "herbal incense," "Cloud 9," "Mojo" and many others, are becoming a large public health concern due not only to their increasing use but also to their unpredictable toxicity and abuse potential.
Brooke, Mills +2 more
openaire +2 more sources
2007
Convincing evidence from preclinical studies demonstrates that cannabinoids can reduce pain responses in a range of inflammatory and neuropathic pain models. The anatomical and functional data reveal cannabinoid receptor-mediated analgesic actions operating at sites concerned with the transmission and processing of nociceptive signals in brain, spinal ...
I J, Lever, A S C, Rice
openaire +2 more sources
Convincing evidence from preclinical studies demonstrates that cannabinoids can reduce pain responses in a range of inflammatory and neuropathic pain models. The anatomical and functional data reveal cannabinoid receptor-mediated analgesic actions operating at sites concerned with the transmission and processing of nociceptive signals in brain, spinal ...
I J, Lever, A S C, Rice
openaire +2 more sources
Current Pharmaceutical Design, 2017
There is growing interest in the relationship between cannabis and psychosis. The link between cannabis use and psychosis comprises three distinct relationships: acute psychosis associated with cannabis intoxication, acute psychosis that lasts beyond the period of acute intoxication, and persistent psychosis not time-locked to exposure.
Deepak Cyril, D'Souza +7 more
openaire +2 more sources
There is growing interest in the relationship between cannabis and psychosis. The link between cannabis use and psychosis comprises three distinct relationships: acute psychosis associated with cannabis intoxication, acute psychosis that lasts beyond the period of acute intoxication, and persistent psychosis not time-locked to exposure.
Deepak Cyril, D'Souza +7 more
openaire +2 more sources
2007
Recent epidemiological studies and advances in understanding of brain cannabinoid function have renewed interest in the long-recognized association between cannabinoids and psychosis. This chapter presents evidence supporting and refuting the association between cannabinoids and psychosis.
openaire +2 more sources
Recent epidemiological studies and advances in understanding of brain cannabinoid function have renewed interest in the long-recognized association between cannabinoids and psychosis. This chapter presents evidence supporting and refuting the association between cannabinoids and psychosis.
openaire +2 more sources
Mini-Reviews in Medicinal Chemistry, 2005
Marijuana has been used in medicine for millennia, but it was not until 1964 that delta9-tetrahydrocannabinol (delta9-THC), its major psychoactive component, was isolated in pure form and its structure was elucidated. Shortly thereafter it was synthesized and became readily available.
openaire +2 more sources
Marijuana has been used in medicine for millennia, but it was not until 1964 that delta9-tetrahydrocannabinol (delta9-THC), its major psychoactive component, was isolated in pure form and its structure was elucidated. Shortly thereafter it was synthesized and became readily available.
openaire +2 more sources
Cannabinoides en epilepsia: eficacia clínica y aspectos farmacológicos
Neurología, 2023Camilo Espinosa-Jovel
exaly
Aplicaciones de los cannabinoides en glaucoma
Archivos De La Sociedad Espanola De Oftalmologia, 2011Rafael Rodriguez-Puertas, Elena Vecino
exaly